CTIS.eu › Cities › Portugal › Lisbon
Lisbon
Portugal
602 total trials
250 recruiting
2023-505739-12-01
5
2024-09-30
Chronic Inducible Urticaria (CINDU)
2023-503692-24-00
5
2024-09-25
Cutaneous Lupus Erythematosus
2023-508219-21-00
5
2024-09-12
BTC - Biliary Tract Cancer
2024-510965-41-00
5
2024-09-03
Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
2024-510908-37-00
5
2024-08-28
KRAS G12C-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (
2023-510178-15-00
5
2024-07-31
High-risk Large B-cell Lymphoma
2023-503923-24-00
5
2024-07-22
Sjögren’s Syndrome With Moderate-toSevere Symptom State
2023-506334-75-00
5
2024-07-12
Pulmonary Arterial Hypertension
2023-505061-82-01
5
2024-06-17
Alopecia Areata
2023-506668-15-00
5
2024-06-17
Relapsed or Refractory Multiple Myeloma (RRMM)
2023-506906-38-00
5
2024-05-23
Follicular Lymphoma
2022-502238-22-00
5
2024-05-14
Ulcerative Colitis
2023-506195-27-00
5
2024-04-05
non-segmental vitiligo
2023-506029-12-00
5
2024-04-03
Migraine
2023-503357-35-00
4
2024-03-20
Non-small Cell Lung Cancer (NSCLC)
2024-511472-32-00
5
2024-03-12
Crohn's Disease
2022-503091-89-00
4
2024-02-15
Delayed graft function
2023-503288-40-00
5
2024-01-26
Unresectable or Metastatic Melanoma
2023-503428-24-00
4
2024-01-19
Neoplasms, Head and Neck
2022-501172-25-00
5
2024-01-17
Chronic and Episodic Migraine
2022-502442-27-00
5
2024-01-08
Obesity
2023-503669-50-00
5
2023-12-27
Moderate-to-Severe Thyroid Eye Disease
2022-502669-14-00
5
2023-12-18
Small cell lung cancer (SCLC)
2022-502975-45-00
5
2023-12-12
Metastatic leiomyosarcoma
Showing 313–336 of 602 trials